Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
The investments have paid off: the global malaria mortality rate fell by 60 percent between 2000 and 2015 .For two consecutive years now, malaria deaths have risen, while funding has flatlined.Eradicating malaria will require new medical and health policy solutions as well as stronger political will.Without a concerted response from the global health community, drug-resistant strains of malaria could spread to Africa and cause more than 100,000 new deaths per year.Since 2000, the global health community has saved millions of lives by responding to specific epidemics like HIV, tuberculosis and malaria.This is a challenging moment in the fight against malaria.For its part, Novartis recently announced that it will invest more than $100 million in antimalarial R&D over the next five years, to help contain emerging resistant strains of the disease.The fight against malaria has been a multidecade marathon. Through the United Nations Sustainable Development Goals, the world has formally committed to ending the malaria epidemic by 2030 .
FOLLOW THIS ARTICLE